Interview 10 Apr 2017
“Alzheimer’s is the Last Unclaimed Therapeutic Space,” says TauRx exec
…planning to expand? Yes, but that requires money. We do have a very interesting candidate for Parkinson’s though, which outperforms LMTX to Alzheimer’s in an in vitro model. This is…
